Onconic Therapeutics Inc. (KOSDAQ:476060)
South Korea · Delayed Price · Currency is KRW 15,800
+950 (6.40%)
Aug 12, 2026, 3:30 PM KST
Onconic Therapeutics Market Cap
Onconic Therapeutics has a market cap or net worth of 674.31 billion as of August 12, 2026. Its market cap has increased by 141.37% in one year.
Market Cap
674.31B
Enterprise Value
617.12B
Revenue
67.20B
Ranking
n/a
PE Ratio
33.67
Stock Price
15,800.00
ChartMarket Cap Chart
Since December 19, 2024, Onconic Therapeutics's market cap has increased from 186.91B to 674.31B, an increase of 260.77%. That is a compound annual growth rate of 118.55%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 10, 2026 | 666.13B | -23.41% |
| Dec 30, 2025 | 869.78B | 392.69% |
| Dec 30, 2024 | 176.54B | -5.55% |
| Dec 19, 2024 | 186.91B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Chabiotech | 899.12B |
| Hyundai Bioscience | 796.15B |
| Pharmicell | 695.45B |
| AbClon | 692.34B |
| GI Innovation | 601.29B |
| Medy-Tox | 508.37B |
| GC Corp. | 486.71B |
| MEDIPOST | 406.49B |